|
Name: Oxazolam
Type: Benzodiazepine
AKA: Serenal, Convertal
|
|
II. Natural Derivative
Synthetic substance, no natural derivative
 |
|
III. Chemical Profile (IUPAC name)
|
|
IV. History
Oxazolam, a benzodiazepine, was introduced in the late 1970s. It was developed to provide anxiolytic and sedative effects, with a focus on treating anxiety and panic disorders. The drug's introduction reflected growing interest in benzodiazepines as alternatives to barbiturates. Oxazolam's use has been widespread in clinical settings, although its potential for dependence and withdrawal symptoms has led to careful management and regulation in prescribing practices.
|
|
V. Legal Information
Oxazolam, a benzodiazepine used for anxiety, is classified as a Schedule IV controlled substance in the US. Globally, its status reflects similar controls to manage its use while preventing misuse and addiction.
US Federal Schedule - IV
Schedule IV drugs, substances, or chemicals are defined as drugs with a low potential for abuse and low risk of dependence. Some examples of Schedule IV drugs are: Xanax, Soma, Darvon, Darvocet, Valium, Ativan, Talwin, Ambien, Tramadol.
Key US Federal Policies:
Controlled Substances Act. Public Law: Public Law 91-513 (text can be found on GovInfo) (https://www.dea.gov/drug-information/csa). Date enacted: October 27, 1970.
|
|
VI. Physical Effects
Oxazolam, a benzodiazepine, is used for anxiety and agitation. As a downer, it induces significant sedation and relaxation. Short-term effects include reduced anxiety and improved relaxation, while long-term use can lead to dependence and cognitive impairment. Overdose risks involve severe sedation and respiratory issues. Safe dosing typically ranges from 10-30 mg daily. Recent research highlights its efficacy and potential for misuse.  |
|
VII. Psychological Effects
Oxazolam, a benzodiazepine, enhances GABA-A receptor activity, providing anxiolytic effects. Immediate effects include reduced anxiety and improved mood, while long-term use may lead to dependence and cognitive decline. Research explores its efficacy for anxiety disorders and potential cognitive side effects.
 |
|
VIII. Culture
Oxazolam is a benzodiazepine with anxiolytic and sedative properties, classifying it as a downer. Short-term use reduces anxiety and induces sleep, while long-term use can lead to dependence and withdrawal symptoms. Overdose risks include severe respiratory depression and potentially fatal outcomes. Safe dosages are medically prescribed, typically under 30 mg per day. Recent research highlights its efficacy in anxiety and insomnia management but warns of addiction risks. Physical effects include drowsiness, dizziness, and impaired coordination.
 |